M & A MEDICS LTD Filleted Accounts Cover |  |

| M & A MEDICS LTD |
|  | Company No. 13554983 |  |
|  |  | Information for Filing with The Registrar |  |  |
|  |  | 31 August 2025 |  |  |

M & A MEDICS LTD Directors Report Registrar |  |

The Director presents his report and the accounts for the year ended 31 August 2025.
Principal activities |  |  |  |  |
The principal activity of the company during the year under review was Providing Medical Consultancy.
Director |  |  |  |  |
The Director who served at any time during the year was as follows:
M. Anwar |  |  |  |  |  |  |
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board |  |  |  |
M. Anwar |  |  |  |  |  |
Director |  |  |  |  |  |
09 May 2026 |  |  |  |  |  |

M & A MEDICS LTD Balance Sheet Registrar |  |

at | 31 August 2025 |  |  |  |  |  |  |
Company No. | 13554983 |  | Notes | 2025 |  |  |  | 2024
|  |  |  |  |  | £ |  |  |  | £
Fixed assets |  |  |  |  |  |  |
| Tangible assets |  | 5 | 3,432 |  |  |  | 137
|  |  |  |  |  | 3,432 |  |  |  | 137
Current assets |  |  |  |  |  |  |
| Cash at bank and in hand |  |  | 32,550 |  |  |  | 9,371
|  |  |  |  |  | 32,550 |  |  |  | 9,371
Creditors: Amount falling due within one year | 6 | (17,525) |  |  |  | (7,967)
Net current assets |  |  | 15,025 |  |  |  | 1,404
Total assets less current liabilities |  |  | 18,457 |  |  |  | 1,541
Net assets |  |  | 18,457 |  |  |  | 1,541
Capital and reserves |  |  |  |  |  |  |
| Called up share capital |  |  | 2 |  |  |  | 2
| Profit and loss account |  | 8 | 18,455 |  |  |  | 1,539
Total equity |  |  | 18,457 |  |  |  | 1,541
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 09 May 2026 and signed on its behalf by: |  |
M. Anwar |  |  |  |  |  |  |
Director |  |  |  |  |  |  |
09 May 2026 |  |  |  |  |  |  |  |

M & A MEDICS LTD Notes to the Accounts Registrar |  |

for the year ended 31 August 2025 |  |  |  |  |  |  |  |

1 | General information |  |
| M & A MEDICS LTD is a private company limited by shares and incorporated in England and Wales.
| Its registered number is: 13554983 |  |  |  |  |  |
| Its registered office is: |  |  |  |  |  |  |  |  |  |
| 2 Walsingham Road |  |  |  |  |  |  |  |  |  |
| Enfield |  |  |  |  |  |  |  |  |  |
| EN2 6EX |  |  |  |  |  |
| The accounts have been prepared in accordance and comply with FRS 102 and Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

2 | Accounting policies |  |  |  |  |  |  |  |

| Revenue recognition |  |  |  |  |  |  |  |
| The Company’s contracts with customers typically include a single performance obligation, being the delivery of provision of services. Revenue is recognised when that performance obligation is satisfied, which is when control passes to the customer.

| Tangible fixed assets and depreciation |  |  |  |  |  |  |  |
| Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses. At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
| Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
|  | Plant and machinery |  | 33.33% Reducing balance |  |  |  |  |  |
|  | Furniture, fittings and equipment |  | 25% Reducing balance |  |  |  |  |  |

| Taxation |  |  |  |  |  |
| Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

| Trade and other creditors |  |  |  |  |  |  |  |
| Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

| Provisions |  |  |  |  |  |  |  |
| Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation. Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet.

3 | Employees |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | Number |  |  |  | Number
|  | The average monthly number of employees (including directors) during the year was: | 1 |  |  |  | 1

4 | Taxation |  |  |  |  |  |  |  |
|  | (a) Tax on profit on ordinary activities |  |  | 2025 |  |  |  | 2024
|  | The tax charge is made up as follows: |  |  |  | £ |  |  |  | £
|  | UK corporation tax |  |  |  |  |  |  |  |
|  | Charge for the period |  |  |  | 3,195 |  |  |  | 283
|  | Total corporation tax |  |  |  | 3,195 |  |  |  | 283
|  | Tax on profit on ordinary activities |  |  |  | 3,195 |  |  |  | 283
|  | (b) Factors affecting the total tax charge for the period |  |  |  |  |
|  | The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The differences are reconciled below:
|  | Higher |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  | 3195 |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Profit on ordinary activities before tax |  |  |  | 20,111 |  |  |  | 1,422
|  | Profit on ordinary activities multiplied by standard rate of corporation tax in the United Kingdom |  | - |  |  |  | -
|  | Expenses not deductible for tax purposes |  | 3,195 |  |  |  | 283
|  | Tax on profit on ordinary activities |  |  |  | 3,195 |  |  |  | 283

5 | Tangible fixed assets |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | Plant and machinery |  | Fixtures, fittings and equipment |  | Total
|  |  |  |  |  |  |  |  |  | £ |  | £ |  | £
|  | Cost or revaluation |  |  |  |  |  |  |  |  |  |
|  | At 1 September 2024 |  |  |  |  |  | 615 |  | - |  | 615
|  | Additions |  |  |  |  |  | 2,125 |  | 2,565 |  | 4,690
|  | At 31 August 2025 |  |  |  |  |  | 2,740 |  | 2,565 |  | 5,305
|  | Depreciation |  |  |  |  |  |  |  |  |  |
|  | At 1 September 2024 |  |  |  |  |  | 478 |  | - |  | 478
|  | Charge for the year |  |  |  |  |  | 754 |  | 641 |  | 1,395
|  | At 31 August 2025 |  |  |  |  |  | 1,232 |  | 641 |  | 1,873
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 August 2025 |  |  |  |  |  | 1,508 |  | 1,924 |  | 3,432
|  | At 31 August 2024 |  |  |  |  |  | 137 |  | - |  | 137

6 | Creditors: |  |  |  |  |  |  |  |
|  | amounts falling due within one year |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2024
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Taxes and social security |  |  |  | 3,195 |  |  |  | 283
|  | Loans from directors |  |  |  | 13,730 |  |  |  | 7,184
|  | Accruals and deferred income |  |  |  | 600 |  |  |  | 500
|  |  |  |  |  |  |  |  |  | 17,525 |  |  |  | 7,967

7 | Share Capital |  |  |  |  |  |  |  |
|  | Ordinary Share Capital

8 | Reserves |  |  |  |  |  |  |  |
|  | Profit and loss account - includes all current and prior period retained profits and losses.

M & A MEDICS LTD 13554983 31 August 2025 01 September 2024 false 09 May 2026 BTCSoftware AP Solution 2025 12.3.03 12.3.03 true 13554983 2024-09-01 2025-08-31 13554983 2025-08-31 13554983 2024-08-31 13554983 core:WithinOneYear 2025-08-31 13554983 core:WithinOneYear 2024-08-31 13554983 core:ShareCapital 2025-08-31 13554983 core:ShareCapital 2024-08-31 13554983 core:RetainedEarningsAccumulatedLosses 2025-08-31 13554983 core:RetainedEarningsAccumulatedLosses 2024-08-31 13554983 countries:UnitedKingdom 2024-09-01 2025-08-31 13554983 bus:RegisteredOffice 2024-09-01 2025-08-31 13554983 core:PlantMachinery 2024-09-01 2025-08-31 13554983 core:FurnitureFittingsToolsEquipment 2024-09-01 2025-08-31 13554983 2023-09-01 2024-08-31 13554983 core:PlantMachinery 2024-09-01 13554983 core:FurnitureFittingsToolsEquipment 2024-09-01 13554983 2024-09-01 13554983 core:PlantMachinery 2025-08-31 13554983 core:FurnitureFittingsToolsEquipment 2025-08-31 13554983 core:RetainedEarningsAccumulatedLosses 2024-09-01 2025-08-31 13554983 bus:SmallEntities 2024-09-01 2025-08-31 13554983 bus:FullAccounts 2024-09-01 2025-08-31 13554983 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 13554983 bus:Director1 2024-09-01 2025-08-31 13554983 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 iso4217:GBP xbrli:pure